Skip to main content
Caplight Logo









Phantom Neuro

Phantom Neuro

Private
Austin, TexasHealthcare & Life Scienceshttps://phantomneuro.com/

Last Round

Grant

Sep 10, 2025

Total Funding Raised

$28.56M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Phantom Neuro is a neurotechnology company developing a minimally invasive neural interface that enables intuitive control of prosthetic limbs and robotic exoskeletons.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Industrial Robotics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

robotic prostheticsneurotechnologybrain-computer interfaceBCIprosthetic controlimplantable sensormuscle-machine interfaceelectromyographybionicsEMGneural interfaceassistive technologymedical deviceexoskeletonhuman augmentation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phantom Neuro Comparables

Compare Phantom Neuro with similar companies based on industry and business-model similarity.

Phantom Neuro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Blue Arbor Technologies, Inc.
88%
Coapt
77%
Esper Bionics
74%

Phantom Neuro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 10, 2025
Series AApr 15, 2025
SeedSep 12, 2022
SeedMar 25, 2022

Phantom Neuro Investors

Notable investors and investment history

Phantom Neuro investors
InvestorRounds
Risk and ReturnSeries A
Brown AdvisorySeries A
Time BioVenturesSeries A, Seed
Risk and ReturnSeries A
Capital FactorySeed
MainSheet VenturesSeries A
E1 VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 33% to 4.3K.

  • Nov 1, 2025

    Launched a registry connecting amputees with neurointerface trials.

Phantom Neuro Filings

Explore SEC and related filing metadata, where available.

Phantom Neuro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Phantom Neuro's valuation, stock price, and market status.

Is Phantom Neuro a public or private company?

Phantom Neuro is a private company.

What is the current stock price of Phantom Neuro?

Phantom Neuro is a private company with no public stock price. No recent secondary market data is available.

How much is Phantom Neuro worth (valuation)?

Valuation information for Phantom Neuro is not publicly available.

Can I buy Phantom Neuro stock?

Phantom Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Phantom Neuro's last funding round?

Phantom Neuro's most recent funding round was Series A on April 15, 2025.

Who are the main investors in Phantom Neuro?

Key investors in Phantom Neuro include Time BioVentures.

Will Phantom Neuro IPO soon?

No public IPO plans have been announced for Phantom Neuro.

How can I track Phantom Neuro secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phantom Neuro's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAustin, Texas
Employee Range16
Year Founded2020
Last FundingSep 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?